Alistair Ring

12PUBLICATIONS
74CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 09, 2026
VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer.

Sara A Hurvitz, Rachel M Layman, Giuseppe Curigliano

|Oct 29, 2025
The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial.

Iseult M Browne, Javier Pascual, Rosalind J Cutts

|Nov 20, 2023
ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast Cancer.

Belinda Kingston, Alex Pearson, Maria Teresa Herrera-Abreu

|Sep 29, 2023
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010).

Alistair Ring, Lucy S Kilburn, Alex Pearson

|Jul 07, 2023
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial.

Nalinie Joharatnam-Hogan, Duaa Hatem, Fay H Cafferty

|May 21, 2021
Impact of timing of adjuvant chemothapy for early breast cancer: the Royal Marsden Hospital experience.

Alicia F C Okines, Emma Kipps, Tazia Irfan

Pageof 2

Frequent Collaborators

5 joint publications

Lucy S Kilburn

5 joint publications

Laura Moretti

5 joint publications

Iain R Macpherson

4 joint publications

Belinda Kingston